What is Typbar Typhoid Vaccine?
Typbar is a Vi capsular polysaccharide vaccine manufactured by Bharat Biotech. It is used for active immunization to prevent typhoid fever caused by Salmonella typhi. This vaccine is an unconjugated version, specifically designed to stimulate the immune system to produce antibodies against the typhoid bacteria.
How it Works
The vaccine contains purified Vi capsular polysaccharide. Once injected, it helps your body develop immunity without causing the disease. It is particularly important for individuals living in or traveling to areas where typhoid fever is common, such as various parts of Nigeria.
Dosage and Administration
Typbar is administered as a single 0.5 mL intramuscular injection, usually in the upper arm (deltoid muscle). It is approved for use in adults and children aged 2 years and older. For continued protection, a booster dose is recommended every 3 years.
Why Choose Typbar?
- Proven Protection: Effectively reduces the risk of contracting typhoid fever.
- Single Dose: Convenient one-time injection for 3 years of coverage.
- NAFDAC Approved: Registered and safe for use in the Nigerian market (NAFDAC No: A6-0446).
Consult with a GoMed pharmacist or your healthcare provider to confirm if this vaccine is suitable for you or your child.